81 – 90 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The thromboxane A2 receptor antagonist Daltroban counteracts acute hypoxic pulmonary vasoconstriction
(
- Contribution to journal › Published meeting abstract
-
Mark
Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).
(
- Contribution to journal › Article
- 2009
-
Mark
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
(
- Contribution to journal › Article
-
Mark
Adverse social factors can predict hypertension--but how?
(
- Contribution to journal › Letter
-
Mark
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Tuberculous pericarditis with constrictive physiology.
(
- Contribution to journal › Article
- 2008
-
Mark
Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy
(
- Contribution to journal › Article
-
Mark
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
(
- Contribution to journal › Article
-
Mark
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
(
- Contribution to journal › Article